Olfr813, a member of the olfactory receptor family, is a key player in the intricate process of olfaction, enabling humans to perceive and discriminate a vast array of odorants in their environment. This G-protein coupled receptor (GPCR) is predominantly expressed in the olfactory sensory neurons of the nasal epithelium and serves as the initial detector of odor molecules. Activation of Olfr813 by odorants triggers a signaling cascade that involves the generation of cyclic adenosine monophosphate (cAMP), leading to the transmission of olfactory information to the brain. This receptor's functionality is essential for our sense of smell and contributes to our ability to identify and react to various odors in our surroundings.
Inhibition of Olfr813 can be achieved through various means, including both direct and indirect approaches. Direct inhibitors, such as Curcumin, bind directly to the receptor, preventing its activation in response to odorants, thereby altering olfactory perception. Conversely, indirect inhibitors, like Nifedipine, modulate cellular processes or signaling pathways closely connected to the receptor's function. For instance, Nifedipine blocks calcium channels, indirectly disrupting Olfr813 signal transmission in olfactory neurons. Understanding these diverse mechanisms of inhibition sheds light on the complexity of olfactory signal processing and provides valuable insights into the intricate world of our sense of smell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol indirectly inhibits Olfr813 by modulating the SIRT1 pathway, affecting receptor sensitivity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine indirectly inhibits Olfr813 by blocking calcium channels, disrupting neuronal signal transduction. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG indirectly inhibits Olfr813 by modulating the Nrf2 pathway and reducing oxidative stress. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin targets PI3-kinase, indirectly affecting Olfr813 by disrupting downstream signaling pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin directly inhibits Olfr813 by binding to the receptor, preventing its activation in response to odorants. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil indirectly inhibits Olfr813 by blocking calcium channels, disrupting neuronal signal transduction. | ||||||
Hemicholinium-3 | 312-45-8 | sc-252873 sc-252873A | 100 mg 500 mg | $84.00 $413.00 | ||
Hemicholinium-3 inhibits choline uptake, indirectly impacting Olfr813 signal transmission in cholinergic neurons. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin indirectly inhibits Olfr813 by modulating the Nrf2 pathway and reducing oxidative stress. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP directly influences Olfr813 by modulating cAMP levels, affecting downstream signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases, indirectly affecting Olfr813 signaling cascades in olfactory neurons. | ||||||